Express Pharma

SEPTEMBER 17, 2023

The World Spice Congress hosted at Mumbai by the Spices Board of India saw the launch of a cardamom-based nutraceutical called Recovereez. Zum Heilen Diagnostic & Therapeutics, a startup company based in Thrissur in Kerala has developed the product and formulation and has been awarded the Indian patent. The product was launched by Amar Singh Bhatia IAS -Chairman Spices Board, D Sathyan, IFS – Secretary Spices Board, and Dr Remahsree, Director, Spices Board.

114

114

Pharmaceutical Business Review

SEPTEMBER 17, 2023

A Final Draft Guidance (FDG) has been issued for QUVIVIQ for the treatment of these patients with symptoms lasting for three nights or more per week for at least three months, and whose daily functioning is significantly affected. This recommendation applies when cognitive behavioural therapy for insomnia (CBTi) has been attempted without success or when it is unavailable or unsuitable.

98

98

Express Pharma

SEPTEMBER 17, 2023

Torque Pharmaceuticals has launched a campaign in honour of World Pharmacist’s Day on September 25, 2023. This film portrays the compassion and dedication demonstrated by pharmacists, showcasing their willingness to go the extra mile in caring for their customers. This initiative seeks to pay tribute to and celebrate pharmacists. Abhay Iqbal Singh Bedi, Director Torque Pharmacueticals said, “On World Pharmacist Day, we pay tribute to the compassionate unsung champions of healing.

69

69

FDA Law Blog: Biosimilars

SEPTEMBER 17, 2023

By Philip Won & Véronique Li, Senior Medical Device Regulation Expert — Over the last three and a half years, meetings with FDA were conducted virtually. During this time, CDRH moved from Webex to Zoom and gained experience with the virtual platform. Now, in addition to engaging with FDA via Zoom, medical device sponsors can once again engage in in-person meetings with the Agency.

59

59

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

EMCrit Project

SEPTEMBER 17, 2023

All the amazing RACC literature for September 2023 EMCrit Project by Scott Weingart, MD FCCM.

76

76

Med Ed 101

SEPTEMBER 17, 2023

ACE Inhibitors have been a workhorse in managing blood pressure for years. While lisinopril is the most commonly used agent that I see in practice, I thought it would be helpful to put together an ACE Inhibitor Comparison table to share with the audience and highlight some important differences. If you’d like more information on […] The post ACE Inhibitor Comparison Table appeared first on Med Ed 101.

52

52

PharmExec

SEPTEMBER 17, 2023

Webinar Date/Time: Thu, Oct 12, 2023 2:00 PM EDT

52

52

Drug Patent Watch

SEPTEMBER 17, 2023

This chart shows the drug companies with the most supplementary protection certificates (SPCs). SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the… The post Which pharma companies have the most supplementary protection certificates? appeared first on DrugPatentWatch - Make Better Decisions.

59

59

Pharmacy Joe

SEPTEMBER 17, 2023

In this episode, I’ll discuss how to predict hypotension from dexmedetomidine. Episode 853: Can hypotension from dexmedetomidine be predicted? Subscribe on iTunes , Android , or Stitcher Dexmedetomidine is a popular sedative for use in critically ill patients. Hypotension is a common side effect that may limit the dose or even use of dexmedetomidine in critically ill patients.

Inpatient 52

Inpatient Hospitals 52